Results from single or combined test can:
• Provide early diagnosis of AMI.
• Enable prognosis of ACS risk assessment & stratification.
• Provide myocardial infarct size estimates.

Tests currently available on the Finecare platform are:
NT-proBNP/Troponin I/H-FABP/CK-MB/Myo/3in1 (Trop, CK-MB, Myo).

Easy to use

  • No analyser calibration required.
  • Virtually maintenance free analyser.
  • Tests only require a small aliquot of venous blood.
  • Familiar cassette technology.
  • Rapid 15 minute read time.

Efficient

  • 25 test kit for low usage sites.
  • Room temperature storage.
  • Long shelf life.
  • All tests provide quantitative results.
  • Wide range of tests are available on the Suresign Finecare Analyser.

Reliable

  • Laboratory standard results.
  • Automated reading eliminates subjectivity & administrative errors.
  • Simple technology = reliable technology.

Demonstrations available Book Now

Downloads

Full Documentation

Find out more about the company behind our brands. From Suresign to Checkpoint CIGA Healthcare is one of the UK’s leaders in Rapid Test Diagnostics.

Visit

Discover our OTC range of products for home testing. From pregnancy to blood pressure Suresign OTC is one of the UK’s leading rapid diagnostic brands.

Visit

Learn more about how Suresign are tackling the ever rising subject of diabetes. Includes information on our diabetes testing & advice on how to manage your condition.

Visit